Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders

被引:0
|
作者
van Zanten, SV [1 ]
机构
[1] Queen Elizabeth 2 Hlth Sci Ctr, Div Gastroenterol, Dalhousie Med Sch, Halifax, NS B3H 2Y9, Canada
关键词
D O I
10.1155/2004/742140
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:749 / 750
页数:2
相关论文
共 50 条
  • [1] Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI
    Heidelbaugh, Joel J.
    Goldberg, Kathleen L.
    Inadomi, John M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S27 - S32
  • [2] The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage
    Spiegel, Brennan M. R.
    Dulai, Gareth S.
    Lim, Brian S.
    Mann, Neel
    Kanwal, Fasiha
    Gralnek, Ian M.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (08) : 988 - 997
  • [3] The cost-effectiveness of high dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy
    Barkun, A
    Adam, V
    Kennedy, WA
    Fallone, CA
    Herba, K
    Bardou, K
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 248 - 248
  • [4] Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus
    Reem Z. Sharaiha
    Daniel E. Freedberg
    Julian A. Abrams
    Y. Claire Wang
    [J]. Digestive Diseases and Sciences, 2014, 59 : 1222 - 1230
  • [5] Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett's Esophagus
    Sharaiha, Reem Z.
    Freedberg, Daniel E.
    Abrams, Julian A.
    Wang, Y. Claire
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (06) : 1222 - 1230
  • [6] DEPRESCRIBING OF PROTON PUMP INHIBITORS IN ELDERLY PATIENTS: A COST-EFFECTIVENESS ANALYSIS
    Xie, M.
    You, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S54 - S54
  • [7] Cost-Effectiveness of Stress Ulcer Prophylaxis: Role of Proton Pump Inhibitors
    Udeh, Belinda L.
    Udeh, Chiedozie
    Hata, J. Steven
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2010, 2 (05) : 302 - 310
  • [8] The cost-effectiveness of IV versus PO proton pump inhibitor (PPI) therapy in the management of high-risk ulcer hemorrhage
    Spiegel, B
    Lim, B
    Dulai, GS
    Mann, N
    Kanwal, F
    Gralnek, IM
    [J]. GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB156 - AB156
  • [9] The cost-effectiveness of high-dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy
    Barkun, AN
    Adam, V
    Kennedy, N
    Fallone, CA
    Herba, K
    Bardou, M
    [J]. GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB149 - AB149
  • [10] Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding
    Enns, RA
    Gagnon, YM
    Rioux, KP
    Levy, AR
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (02) : 225 - 233